Dr. Lal PathLabs Limited (LALPATHLAB) Gross Profit 2023–2026

Name: Dr. Lal PathLabs Limited (LALPATHLAB) gross profit history 2023-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-20

Dr. Lal PathLabs Limited annual gross profit for fiscal 2026 was ₹22.3 billion, an increase of 12.5% from ₹19.8 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

LALPATHLAB Annual Gross Profit

Gross Profit (annual)	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Gross Profit	₹22.3B	₹19.8B	₹14.6B	₹12.9B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LALPATHLAB Quarterly Gross Profit

Gross Profit (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Gross Profit	₹5.3B	₹5.7B	₹4.4B	—	₹4.5B	₹4.8B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Gross Profit at Comparable Companies

2359 Gross Profit — WuXi AppTec Co., Ltd.
SAILIFE Gross Profit — Sai Life Sciences Limited
4544 Gross Profit — H.U. Group Holdings, Inc.

More LALPATHLAB metrics: Revenue · Operating Income · Net Income · EPS · Free Cash Flow

All LALPATHLAB financial statements → Interactive LALPATHLAB charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.